-
Human Microbiome Based Drugs Diagnostics Market Growth at a CAGR of 19.03% to Hit 85.7 Billion USD by 2032 | EMD Serono
31 Jan 2025 07:40 GMT
… Pharmaceuticals
4D pharma
Clostridium
EMD Serono
Danone
AkesoBiome
Nestle
GITherapeutics
Get … &report_id=618130
Key Benefits:
The Human Microbiome Based Drugs …
-
‘Don’t give up’: Long-term lebrikizumab for AD may benefit initial nonresponders
29 Jan 2025 21:15 GMT
… an initial response can still benefit from continuation of long-term … , Eli Lilly and Company, EMD Serono, Evidera, Galderma, Incyte Corporation, Innovaderm …
-
Merck KGaA, Darmstadt, Germany Announces Launch of Caregiver Leave Benefit, Strengthening Inclusive Family-Friendly Offerings
22 Jan 2025 14:30 GMT
… with any existing leave benefits or regulatory requirements that … training and upskilling to benefit caregivers and their loved ones … in life science, EMD Serono in healthcare and EMD Electronics … the U.S. as EMD Serono, MilliporeSigma and EMD Electronics, …
-
Newly illuminated molecular roots of lupus may lead to treatments with ‘durable benefits’
04 Oct 2024 11:41 GMT
… , this approach may offer durable benefits.”
As a result, the study … as research grants from EMD Serono and Zenas Biopharma.
Add topic …
-
DTC Rheumatologic Tests Carry Some Benefit, Potential Risk
27 Sep 2024 13:40 GMT
… diseases.
Timothy Niewold, MDRisks vs Benefits
DTC testing is not an … , and Kim worry outweigh potential benefits. On the one hand, getting … receiving research grants from EMD Serono and Zenas BioPharma and consulting …
-
Intravenous golimumab shows long-term benefit for juvenile idiopathic arthritis
16 Sep 2024 23:19 GMT
… week 116 suggest a therapeutic benefit with continued IV golimumab treatment … reported here, an acceptable risk-benefit profile.”
Sources/DisclosuresCollapse
Disclosures … Squibb, Celgene, Eli Lilly, EMD Serono, Genzyme, GlaxoSmithKline, F. Hoffman-La …
-
Retifanlimab Plus Carboplatin and Paclitaxel Offers PFS Benefit in Recurrent/Metastatic SCAC
14 Sep 2024 22:10 GMT
… progression-free survival (PFS) benefit with the addition of … “We have demonstrated a benefit by adding retifanlimab to SOC … , Bayer, BeiGene, Hookipa, Merck Serono, Seagen, Takeda, and Servier; … speaker for Bayer, Merck Serono, and Servier; received travel …
-
EMD Serono Unveils New MAVENCLAD® Four-Year Data Highlighting Benefits of Early Treatment and Sustained Efficacy Across Multiple Measures of Disease Activity
12 Sep 2024 13:16 GMT
… experienced patients), emphasizing the benefits of early treatment initiation with … and unpredictable disease. EMD Serono is digging deeper to … science.
About EMD Serono, Inc.
EMD Serono - the healthcare … in life science, EMD Serono in healthcare, and EMD …
-
Durvalumab Plus Chemo Shows Sustained Survival Benefit in Advanced Biliary Tract Cancer
19 Jul 2024 15:54 GMT
The overall survival (OS) benefit derived by adding durvalumab (Imfinzi) … , J-Pharma, LG Chem, Merck Serono, Mirati Therapeutics, Moderna, MSD, Novartis …
-
Durvalumab Plus Chemo Maintains OS Benefit in Advanced Biliary Tract Cancer
01 Jul 2024 21:27 GMT
… a sustained overall survival (OS) benefit vs chemotherapy alone in patients … , J-Pharma, LG Chem, Merck Serono, Mirati Therapeutics, Moderna, MSD, Novartis …